PTSM: Pharmaceutical Technology Sourcing and Management, Oct 5, 2011 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Oct 5, 2011
A Changing Paradigm for Pharmaceutical Chemical Outsourcing
By Patricia Van Arnum
Industry experts share perspectives on the changing fundamentals and business models for outsourcing pharmaceutical chemical development and manufacturing
A Mixed Review for Biotechnology Financing
By Patricia Van Arnum
The biotechnology industry achieved aggregate profitability in 2010 and funding improved, but levels of innovation capital still lag.
The EU Debt Crisis and CMOs
By Jim Miller
The EU debt crisis portends of possible negative repercussions for the dose CMO industry.
CSR and Sustainability Forum
UN General Assembly Addresses Issue of Noncommunicable Diseases in the Developing World
By Patricia Van Arnum
The United Nations calls for a multistakeholder plan by 2013 to curb the rise of noncommunicable diseases.
Pharmaceutical Industry Prioritizes Its Action Plan for Tackling Noncommunicable Diseases
By Patricia Van Arnum
The International Federation of Pharmaceutical Manufacturers and Associations offers an action plan and research for addressing noncommunicable diseases.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here